| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 23 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 20 |
| 2 | TACROLIMUS OINTMENT 0.1% | 20 |
| 3 | EVEROLIMUS | 14 |
| 4 | EVEROLIMUS TABLETS | 14 |
| 5 | HYDROXYUREA | 14 |
| 6 | ITRACONAZOLE | 14 |
| 7 | LAMIVUDINE | 14 |
| 8 | LAMIVUDINE ORAL | 14 |
| 9 | PREDNISOLONE | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ITRACONAZOLE | 14 | 0.0012 |
| 1 | PIMECROLIMUS | 2 | 0.0011 |
| 2 | EVEROLIMUS TABLETS | 14 | 0.0008 |
| 3 | VALGANCICLOVIR | 13 | 0.0007 |
| 4 | HYDROXYUREA | 14 | 0.0007 |
| 5 | LAMIVUDINE | 14 | 0.0006 |
| 6 | NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE | 3 | 0.0004 |
| 7 | EVEROLIMUS | 14 | 0.0003 |
| 8 | IVERMECTIN | 1 | 0.0002 |
| 9 | FINASTERIDE | 13 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 13 | 0.0006 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 14 | 0.0003 |
| 2 | Antiparasitic [EPC] | 1 | 0.0002 |
| 3 | Pediculicide [EPC] | 1 | 0.0002 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 14 | 0.0001 |
| 5 | 5-alpha Reductase Inhibitor [EPC] | 13 | 0.0001 |
| 6 | Nitroimidazole Antimicrobial [EPC] | 7 | 0.0001 |
| 7 | Integrin Receptor Antagonist [EPC] | 9 | 0.0001 |
| 8 | Azole Antifungal [EPC] | 14 | 0.0001 |
| 9 | Barbiturate [EPC] | 1 | 0.0001 |